Bulk Chemicals, Inc. – Trademark Portfolio
Entity Type: 03
Bulk Chemicals, Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 6 filings in this category. The portfolio also extends into Class 2 (Paints) across 3 Nice Classification classes. Currently, 10 trademarks are registered. Notable registered marks include BDACS, E-CLPS, TRI-CLPS, BULK BOND, and BULK DRAW. The owner is based in Reading, PA.
1074 Stinson Drive
Reading, PA 19605
Showing of trademarks Trademarks
Trademark Classifications
Bulk Chemicals, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Paints, varnishes, lacquers; preservatives against rust and against deterioration of wood
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Bulk Chemicals, Inc. have?
Bulk Chemicals, Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 10 registered, 1 abandoned.
What trademark classes does Bulk Chemicals, Inc. file in?
Bulk Chemicals, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 2 (Paints), Class 9 (Computers & Electronics). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Bulk Chemicals, Inc.'s most well-known trademarks?
Bulk Chemicals, Inc.'s registered trademark portfolio includes well-known marks such as BDACS, E-CLPS, TRI-CLPS, BULK BOND, and BULK DRAW. These are among 10 currently registered trademarks in the portfolio.
What is Bulk Chemicals, Inc.'s trademark registration success rate?
Bulk Chemicals, Inc. has a 91% trademark registration rate, with 10 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.